Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer: Practical Training on Individualizing CDK4/6 Inhibitor Treatment to Enhance Adherence, Quality of Life, and Outcomes
Chair Stephanie L. Graff, MD, FACP, FASCO, discusses breast cancer in this CME/MOC/NCPD/CPE/AAPA/IPC...
58 slides
246
Technology
PeerView